SCA
MD icon

Snowden Capital Advisors’s Pediatrix Medical MD Stock Holding History

Snowden Capital Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,895
Closed -$1.08M – 298
2016
Q2 		$1.08M Buy
+14,895
New +$1.02M 0.33% 108

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Snowden Capital Advisors's MD Position: Q3 2016 in Review

Snowden Capital Advisors sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 14,895 shares — an estimated $1.08M sold.

Snowden Capital Advisors first reported a position in MD in Q2 2016 and held it in 1 quarter. The position peaked at $1.08M in Q2 2016. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

  • Snowden Capital Advisors reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
  • Snowden Capital Advisors sold 14,895 Pediatrix Medical shares in Q3 2016, an estimated $1.08M.
  • Snowden Capital Advisors first reported a position in Pediatrix Medical in Q2 2016 and held it in 1 quarter.
  • Snowden Capital Advisors's Pediatrix Medical position peaked at $1.08M in Q2 2016.
  • 381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on Snowden Capital Advisors's 13F filing for Q3 2016, filed 8 Jan 2024.